ursolic acid has been researched along with lamivudine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fong, HH; Mesecar, AD; Nguyen, MC; Nguyen, QC; Nguyen, VH; Pezzuto, JM; Santarsiero, BD; Soejarto, DD; Tan, GT | 1 |
| Dai, Z; Teng, Y; Wu, B; Xu, Y; Zhong, Y | 1 |
| Wang, J; Wang, Y; Wu, B; Zhong, Y | 1 |
| Huang, H; Li, Z; Liu, R; Min, Q; Zhu, Q; Zhu, Y | 1 |
4 other study(ies) available for ursolic acid and lamivudine
| Article | Year |
|---|---|
New 3-O-acyl betulinic acids from Strychnos vanprukii Craib.
Topics: Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Betulinic Acid; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Molecular Structure; Pentacyclic Triterpenes; Plant Leaves; Plants, Medicinal; Stereoisomerism; Strychnos; Triterpenes; Tumor Cells, Cultured | 2004 |
Synthesis, stability and pharmacological evaluation of a novel codrug consisting of lamivudine and ursolic acid.
Topics: Animals; Antiviral Agents; Chemical and Drug Induced Liver Injury; Drug Combinations; Drug Stability; Ducks; Half-Life; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Humans; Hydrogen-Ion Concentration; Hydrolysis; Lamivudine; Lipase; Mice; Mice, Inbred ICR; Plasma; Prodrugs; Protective Agents; Random Allocation; Triterpenes; Ursolic Acid | 2012 |
Preparation and evaluation of liposome-encapsulated codrug LMX.
Topics: Animals; Antiviral Agents; Biological Availability; Drug Combinations; Drug Compounding; Drug Stability; Intestinal Absorption; Lamivudine; Liposomes; Particle Size; Protective Agents; Rats; Rats, Sprague-Dawley; Triterpenes; Ursolic Acid | 2012 |
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
Topics: Antiviral Agents; DNA Replication; Dose-Response Relationship, Drug; Drug Design; Hepatitis B Surface Antigens; Hepatitis B virus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triterpenes | 2018 |